Management of Erythrocytosis

Diagnostic Approach

The American Heart Association recommends determining if erythrocytosis is primary or secondary to identify the underlying cause of the condition 4
Evaluate patients for symptoms of hyperviscosity, including headache, visual disturbances, fatigue, and poor concentration, as recommended by the American College of Cardiology 3, 4

The American College of Cardiology recommends ensuring adequate hydration as first-line therapy for all patients with erythrocytosis 3, 4
Identify and treat underlying causes of secondary erythrocytosis, such as hypoxemia, sleep apnea, or cyanotic heart disease, as recommended by the American Heart Association 4
Avoid routine or repeated phlebotomies due to the risk of iron depletion, decreased oxygen-carrying capacity, and increased stroke risk, as warned by the American College of Cardiology 1, 2, 3

Perform therapeutic phlebotomy when hemoglobin exceeds 20 g/dL and hematocrit exceeds 65%, with associated symptoms of hyperviscosity and no evidence of dehydration, as recommended by the American College of Cardiology 1, 2
The American Heart Association recommends phlebotomy for patients with hyperviscosity symptoms, such as headache, fatigue, and poor concentration 1, 3

Remove 1 unit of blood (400-500 mL) and provide equal volume replacement with isotonic saline or dextrose solution, as recommended by the American College of Cardiology 2, 5
Administer replacement fluids simultaneously with blood removal to maintain intravascular volume, as recommended by the American Heart Association 5

The European Society of Cardiology recommends monitoring cyanotic congenital heart disease patients for hemostatic abnormalities, which occur in up to 20% of patients 1, 6
Erythrocytosis is a physiological response to chronic hypoxemia to improve oxygen transport, as explained by the European Heart Journal 7, 2

Monitor iron status regularly in patients undergoing repeated phlebotomies, as recommended by the American College of Cardiology 2, 4
Iron deficiency in erythrocytosis can paradoxically worsen symptoms by reducing oxygen-carrying capacity and red cell deformability, as warned by the American Heart Association 1, 3

Consider erythrocytapheresis in selected cases where phlebotomy is not feasible, as recommended by the Journal of Hepatology 9
Iron chelation therapy can be considered as a second-line option when phlebotomy is not possible, after careful risk-benefit assessment, as recommended by the Journal of Hepatology 9

Avoid performing routine phlebotomies without meeting established criteria (Hgb >20 g/dL, Hct >65%), as warned by the American College of Cardiology 1, 2, 3
Creating iron deficiency through excessive phlebotomy can paradoxically worsen symptoms, as warned by the American Heart Association 1, 3, 4

Regularly follow up with complete blood counts to monitor hemoglobin and hematocrit, as recommended by the American College of Cardiology 3
Periodically assess iron status to avoid iron deficiency, as recommended by the American Heart Association 3, 4
Monitor for symptoms of hyperviscosity or thrombotic complications, as recommended by the American College of Cardiology 3, 4
Evaluate renal function, as chronic erythrocytosis can affect renal glomeruli, as recommended by the European Heart Journal 7, 4